The Centre of Research Excellence (CRE) to Reduce Inequality in Heart Disease focuses on improving the heart health and outcomes of groups and communities i.e. Regional Australians, Indigenous Australians and International Health

Doctor Jennifer Whitty

Dr Jennifer Whitty is Deputy Director of the Population and Social Health Research Program, Griffith Health Institute,

a Senior Lecturer with the Centre for Applied Health Economics at the School of Medicine, Griffith University, and an Honorary Senior Fellow with the School of Medicine, University of Queensland. She has considerable research leadership and consultancy experience in health economics and health services research, including in pharmacoeconomics, economic evaluation, and health technology assessment.

 

Dr Whitty leads a program of research centred on eliciting public and decision-maker preferences and choices

around healthcare, and using these preferences to inform economic evaluation and health care decision-making.

Her research is also developing methodologies for measuring preferences and valuing quality of life, and she is an expert in the application of choice-based stated preference methods such as the Discrete Choice Experiment. In 2010, she was awarded a prestigious Smart Futures Fellowship by the Queensland Government to support her research. Dr Whitty is the leading health economics investigator for research projects funded by the Australian Research Council (ARC) and National Health and Medical Research Council (NHMRC), including the Centre of Research Excellence in Telehealth. Jennifer has published in numerous peer-reviewed journals and is a member of the Editorial Board for the international journals “Medical Decision Making” and “Applied Health Economics and Health Policy”.  The impact of her research was recently recognised when she was awarded Griffith University’s Vice Chancellor Award for Research Excellence.

 

Dr Whitty's first qualification is as a pharmacist, and she has diverse experience in pharmacy practice.  As a registered pharmacist, she has completed a Graduate Diploma in Clinical Pharmacy, and has undertaken roles in clinical and policy settings in the UK and Australia. Jennifer’s research has retained a particular focus on the evaluation of health technologies including pharmaceuticals. She has worked closely with Queensland Health in the development of their health technology assessment processes, and is an experienced evaluator of submissions made by pharmaceutical companies to have their products listed on the Australian Pharmaceutical Benefits Scheme (PBS).

 

Dr Whitty is a Senior Research Fellow with the CRE to Reduce Inequality of Heart Disease. She leads studies evaluating patient and public preferences for the prevention and treatment of cardiovascular disease for a range of projects under the CRE, including the Which Heart failure Intervention is most Cost effective in reducing Hospital care (WHICH I and WHICH II) Trials. She applies these preferences to assess the value for money provided by cardiovascular interventions within an economic framework; the point of difference from conventional economic evaluation is the strong focus on the perspective of consumers.

 

Jennifer employs innovative methods for assessing preferences around cardiovascular health such as the Discrete Choice Experiment. She holds international collaborations advancing these methods with researchers in Europe and the UK. Her research helps ensure health care resources are allocated to improve the cardiovascular health of Australians efficiently and in accordance with the wishes of patients and society.

 

The CRE is supporting Jennifer to further build her research collaborations and streamline her exisiting program evaluating preferences in healthcare towards improving the value and acceptability of cardiovascular  health interventions. Jennifer’s research focus on assessing preferences, indices of wellness and illness, and societal value in health economics, emphasising the perspective of patients and society in cardiovascular health and decision-making, is unique in Australia.

 

1.Hirst N, Whitty JA, Eely D, Scuffham PA.  Predictors of Government Subsidised Pharmaceutical use in Patients With Diabetes or Cardiovascular Disease in a Primary Care Setting: Evidence from a prospective randomised trial.  Journal of Medical Economics 2011; 14(6):698-70.

2.  Whitty JA, Stewart S, Carrington MJ, Calderone A, Marwick T, Horowitz J, Krum H, Davidson PM, Macdonald PS, Reid C, Scuffham PA. Patient preferences and willingness-to-pay for a home or clinic based program of chronic heart failure management: Findings from the WHICH? Trial. PLOS One 2013;8(3): e58347. doi:10.1371/journal.pone.0058347.

3.  Whitty JA, Carrington MJ, Stewart S, Holliday J, Marwick T, Scuffham PA. Patient preferences for the delivery of disease management in Chronic Heart Failure: A qualitative study. Journal of Cardiovascular Nursing 2012; 27 (3): 201-7